Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cindy Fishman

6PUBLICATIONS

15CO-AUTHORS

Toxicology (incl. clinical toxicology)BiomaterialsPharmacogenomicsMedical infection agents (incl. prions)Infant and child health

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 15, 2025

Evaluation of Biomarkers to Detect Early Prothrombotic Imbalance in Rat Models of Hypercoagulability Induced by Thromboplastin Infusion and Hypofibrinolysis Induced by Tranexamic Acid.

Marjory B Brooks, Cindy E Fishman, Mohanapriya Kamalakannan

|Feb 15, 2024

Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.

Jamese J Hilliard, Charles Jakielaszek, Frank Mannino

|Jun 03, 2023

A phase I, first-in-human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937.

Paul D Benn, Ying Zhang, Lesley Kahl

|Apr 25, 2023

Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge.

Charles Jakielaszek, Jamese J Hilliard, Frank Mannino

|Oct 18, 2022

Novel Bacterial Topoisomerase Inhibitor Gepotidacin Demonstrates Absence of Fluoroquinolone-Like Arthropathy in Juvenile Rats.

Cindy Fishman, Jessica M Caverly Rae, Lorraine M Posobiec

|Jun 01, 2022

Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.

Charles Jakielaszek, Mohammad Hossain, Lian Qian

Pageof 1

Frequent Collaborators

3 joint publications

Charles Jakielaszek

3 joint publications

Karen O'Dwyer

1 joint publications

Paula Katavolos

1 joint publications

Claire E O'Brien

1 joint publications

Florence Poitout-Belissent

1 joint publications

A Eric Schultze

1 joint publications

Mohammad Hossain

1 joint publications

Lian Qian

1 joint publications

Katherine Widdowson

1 joint publications

Jamese J Hilliard

Frequent Collaborators

3 joint publications

Charles Jakielaszek

3 joint publications

Karen O'Dwyer

1 joint publications

Paula Katavolos

1 joint publications

Claire E O'Brien

Top Related Videos

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on : Aug 04, 2023

Antibiotic Efficacy Testing in an Ex vivo Model of <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> Biofilms in the Cystic Fibrosis Lung

Antibiotic Efficacy Testing in an Ex vivo Model of <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> Biofilms in the Cystic Fibrosis Lung

Published on : Jan 22, 2021

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos

Top Related Videos

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on : Aug 04, 2023

Antibiotic Efficacy Testing in an Ex vivo Model of <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> Biofilms in the Cystic Fibrosis Lung

Antibiotic Efficacy Testing in an Ex vivo Model of <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> Biofilms in the Cystic Fibrosis Lung

Published on : Jan 22, 2021

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos